PoCoG Supported Studies - CONCEPTS Developed 2019-20
PoCoG-2011-07: ConquerFear Advanced: A randomized
control trial to reduce fear of cancer recurrence in patients with advanced
disease
Aim: To evaluate in a randomised
controlled trial, the efficacy of an intervention (Conquer Fear Advanced) based
on a novel model of cancer-related anxiety and a proven intervention, in
reducing the impact of fear of cancer recurrence (FCR) in cancer survivors with
advanced disease.
Investigator Team: Louise Sharpe, Phyllis Butow, Jane Turner,
Belinda Thewes, Jane Beith, Ben Smith
Status: Awaiting funding
PoCoG-2011-09: iConquerFear: A randomised
controlled trial of an online self-management intervention to reduce fear of
cancer recurrence
Aim: To evaluate the efficacy of iConquerFear, an
online self-management intervention, in reducing fear of cancer recurrence
(FCR) severity (primary outcome) and ameliorating FCR-related outcomes
including cancer-related distress, anxiety, depression, and healthcare
utilisation/costs (secondary outcomes), in curatively-treated cancer survivors,
compared with an attention control (online relaxation training) in a randomised
controlled trial (RCT).
Investigator Team: Ben Smith, Louise Sharpe, Phyllis Butow, Jane
Turner, Belinda Thewes, Jane Beith
Status: Awaiting funding
PoCoG-2018-15: Light Enhanced Cognitive Behavioural
Therapy (CBT+) for Sleep and Fatigue: A Randomized Controlled Trial during
Chemotherapy for Cancer
Aim: Aim 1 Test the efficacy of cognitive behavioural
and bright light therapy (CBT+) compared to relaxation audio and basic
psychoeducation (CONTROL) for improving symptoms of sleep disturbance and
fatigue. Aim 2 Test the efficacy of CBT+ versus CONTROL for psychological
outcomes. Aim 3 Exploratory aim to test potential mechanisms and moderators of
the intervention efficacy.
Investigator Team: Joshua Wiley, Bei Bei,
Sheila Garland, Sonia Ancoli-Israel, Haitham Tuffaha
Status: In development
PoCoG-2019-201: Ensuring
equity and access to optimal health care: Applying patient reported outcome
measures to guide resource allocation, health system performance and individual
care.
Aim: To develop
systematic approaches to routine application of PROMs accessible to all, with
provision of meaningful individual and aggregated PROMs data to patients,
clinicians and health system decision makers, to influence all levels of
healthcare.
Investigator
team: Phyllis
Butow, Rosalie Viney, Gail Garvey, Haryana Dhillon, Joanne Shaw
Status: On hold
PoCoG-CDW-2019-02: Randomised control
trial of a multi-disciplinary intervention for the management of fatigue in
community palliative care: A feasibility study
Aim: To determine the feasibility of a multi-modal intervention for fatigue
in patients with advanced life-limiting illness referred to a community
palliative care setting
Investigator team: Dr Gemma Ingham, Dr Katalin Urban
Status: In development by CST
PoCoG-2019-401:
iScreen - every cancer patient every need
Aim:
To implement a systemic approach to
online screening of cancer patients for their unmet needs and distress and
address these needs using an evidence-based clinical pathway.
Investigator
team: Bogda
Koczwara, Phyllis Butow, Lisa Beatty, Joanne Shaw, Heather Shepherd, Haryana
Dhillon
Status:
In
development
PoCoG-CDW-2019-01: Cancer-Related
Fatigue Clinic Study
Aim: Phase 1: To develop a CRF Clinic Model of Care and
test the feasibility and acceptability of a CRF Clinic and Phase 2: To test the
effectiveness of the CRF Clinic compared to usual care and to test the
cost-effectiveness of a CRF Clinical model of care compared to usual care.
Investigator team: Ray Chan, Patsy Yates, Carmelita Escalante
Status: In development
PoCoG-CDW-2019-05: Reducing CVD risk
after a cancer diagnosis among indigenous and non-indigenous Australians
Aim: To provide a systems-wide perspective of CVD in
cancer, by investigating, for NSW residents diagnosed with cancer over a
10-year period:
·
The prevalence of
pre-existing and treatment-induced CVD in people diagnosed with cancer and its
effect on their clinical course, outcomes and health care use/cost
·
Variations in the
above between Aboriginal and Torres Strait Islander people and non-Indigenous
people, and by country of birth, sex, age group, cancer type, remoteness and
area-level socioeconomic status.
Investigator Team: Abbey Diaz, Aaron Sverdlov Kalinda Griffiths Joanne
Shaw Doan Ngo Joan Cunningham Brian Kelly Gail Garvey Emily Callander Lisa Whop
Nick Zdenkowski
Status: Awaiting funding
PoCoG-2019-05:
Phase II trial evaluating web-based cognitive behaviour for sleep disturbance
in early stage breast cancer patients on (neo) adjuvant chemotherapy
Aim: To assess the feasibility and acceptability of
web-based cognitive behaviour for sleep disturbance in early stage breast
cancer patients during treatment.
Investigator
Team: Emma-Kate Carson,
Belinda Kiely, Janette Vardy, Haryana Dhillon
Status: In development
PoCoG-2020-03:
LATER (life after cancer) Study: Online platform for managing symptoms
Aim: To
develop and evaluate
an online platform delivering evidence-based interventions to reduce common
symptoms matched to individual need for women cancer patients to improve
quality of life.
Investigator
Team: Michelle Peate,
Martha Hickey, Jennifer Marino, Michael Jefford, Christobel Saunders, Debra
Anderson, Michael Friedlander, Bruce Mann, Ines Rio, Nicole Kinnane
Status: Awaiting funding
PoCoG-2020-02: Impact
of the COVID-19 pandemic on care of patients with cancer and multimorbid
conditions
Aim: To
ensure the delivery
of patient-centred care in the face of COVID-19 and beyond, understanding
patient perceptions and experiences is crucial. Our aim is to capture
perceptions, experiences and concerns about cancer and multimorbidity
management now and over the next 3-12 months.
Investigator
Team: Jasmine Yee, Haryana
Dhillon, Bogda Koczwara, Jon Emery, Claudia Rutherford, Raymond Chan, Kristi
Milley, Sharon Lawn
Status: In development